KDM1A-IN-29
CAS No. 1423715-30-3
KDM1A-IN-29( —— )
Catalog No. M37602 CAS No. 1423715-30-3
KDM1A-IN-29 is a histone demethylase inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 459 | In Stock |
|
| 10MG | 657 | In Stock |
|
| 25MG | 1026 | In Stock |
|
| 50MG | 1386 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameKDM1A-IN-29
-
NoteResearch use only, not for human use.
-
Brief DescriptionKDM1A-IN-29 is a histone demethylase inhibitor.
-
DescriptionKDM1A-IN-29 is a histone demethylase inhibitor.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayChromatin/Epigenetic
-
TargetHistone Demethylase
-
RecptorHistone Demethylase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1423715-30-3
-
Formula Weight381.83
-
Molecular FormulaC16H16ClN3O4S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(N/N=C(\C)/C1=C(O)C=CC(Cl)=C1)(=O)C2=CC(S(NC)(=O)=O)=CC=C2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
T-448
T-448 (T448) is a specific inhibitor of LSD1 enzyme activity, enhances H3K4 methylation in primary cultured rat neurons but has little impact on LSD1-GFI1B complex in human TF-1a erythroblasts.
-
PFI-90
PFI-90 is a selective inhibitor of histone demethylase (KDM3B) that inhibits PAX3-FOXO1 action.PFI-90 has the potential for the antitumor activity.
-
JQKD82
JQKD82 is a selective inhibitor of KDM5 and increases H3K4me3. JQKD82 can be used in studies about the treatment of multiple myeloma.
Cart
sales@molnova.com